01-23-2008, 02:21 AM
|
#1
|
|
Status: Junior Member
Join Date: Jul 2007
Posts: 53
|
SAM-e and Prolactin
Int Clin Psychopharmacol 1987 Apr;2(2):97-102
The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
Thomas CS, Bottiglieri T, Edeh J, Carney MW, Reynolds EH, Toone BK
Twenty subjects entered a double-blind placebo-controlled trial of SAM in
depression. Prolactin concentrations were measured before and after 14 days'
treatment. There was a highly significant fall in prolactin concentrations in
the SAM-treated group.
OR/AND
J Psychiatr Res 1990;24(2):177-84
Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative
antidepressant.
Fava M, Rosenbaum JF, MacLaughlin R, Falk WE, Pollack MH, Cohen LS, Jones L,
Pill L
Clinical Psychopharmacology Unit, Massachusetts General Hospital, Harvard
Medical School, Boston 02114.
S-adenosyl-L-methionine (SAMe), a putative antidepressant, is a naturally
occurring substance whose mechanism of action is still a matter of speculation.
It has been recently postulated that SAMe may increase the dopaminergic tone in
depressed patients. Since dopamine inhibits both thyrotropin (TSH) and
prolactin secretion, we investigated the effects of treatment with SAMe on the
TSH and prolactin response to thyrotropin-releasing-hormone (TRH) stimulation
in 7 depressed outpatient women (mean age: 46.1 +/- 7.2 years) and 10 depressed
outpatient men (mean age: 38.0 +/- 10.0 years) participating in a six-week open
study of oral SAMe in the treatment of major depression. At the end of the
study, there was a significant reduction after treatment with SAMe in the
response of both prolactin and TSH to TRH stimulation in the group of depressed
men compared to pre-treatment values. On the other hand, in the group of
depressed women, the posttreatment prolactin response to TRH did not appear to
change when compared to pre-treatment and the TSH response to TRH challenge
tended even to augment slightly after treatment with SAMe. Our results, at
least in depressed men, seem to support the hypothesis of a stimulating effect
of SAMe on the dopaminergic system.
Now is it going to be a strong effect so that cabergoline and its ilk can be replaced in the setting of prolactin-induced gyno prevention?
Lord i need more time to read
P.S. if you want the second studies full text dinoiii, i can send it to you
|
|
|
|
01-23-2008, 09:06 AM
|
#2
|
|
Status: IFFI Control Tower
Join Date: Jun 2007
Location: Columbus, OH / Rochester, NY / Baltimore, Md / Others
Posts: 2,772
|
Hey Owen,
There are two suggested mechanisms at work here:
[1] SAMe does upregulate dopaminergic systems (which is cited effectively by the second study authors) and as I am certain many of you recall...dopamine acts as an inhibitory molecule on Prolactin secretion.
-and-
[2] There is a estrogen inhibitory effect of SAMe. Recall, high circulating estrogen concentrations do, in effect, promote prolactin secretion - which we know happens with many of the gentlemen coming out of a highly-suppressive cycle.
The distinction between cabergoline and SAMe in regards to stimulation of the dopaminergic system (and subsequently prolactin inhibition and/or antidepressant actions) is really summed up with this basic thought:
SAMe: improves dopamine receptor site binding; quick onset and short-acting
Cabergoline (Dostinex): dopamine agonist; quick onset BUT long-acting
So, an effective answer to your question is NO - it isn't exactly the same nor will it likely provide the same level of prolactin inhibition. What I could see happening is starting someone with prolactin-induced gyno etc... with Cabergoline and transferring them into SAMe dosing. SAMe "may" aid cabergoline binding overall, but this is really unclear at this point. This will likely show up in future research for sure.
D_
__________________
Dana Houser, MD, MHSA, CISSN
Professional Associations: AACE, TES, ADA, ACP, ATA, PS, TOS, NLA, ASBMR, SHM, IHS, HPTHA, NSCA, ISSN
askdinoiii@hotmail.com
The Clinical Underground Official Newsletter (Volume I, Issues I & II now available) ... send "subscribe" email to the address above.
Disclaimer: Despite my being a physician, the information provided in my posts is intended for INFORMATIONAL PURPOSES ONLY and to stimulate increased rapport between physician and patient. It is asked that you embark on advice provided solely by your EXAMINING physician.
Please do NOT email, PM for scripts or referral.
|
|
|
|
01-23-2008, 01:00 PM
|
#3
|
|
Status: Junior Member
Join Date: Jul 2007
Posts: 53
|
Quote:
Originally Posted by dinoiii
Hey Owen,
There are two suggested mechanisms at work here:
[1] SAMe does upregulate dopaminergic systems (which is cited effectively by the second study authors) and as I am certain many of you recall...dopamine acts as an inhibitory molecule on Prolactin secretion.
-and-
[2] There is a estrogen inhibitory effect of SAMe. Recall, high circulating estrogen concentrations do, in effect, promote prolactin secretion - which we know happens with many of the gentlemen coming out of a highly-suppressive cycle.
The distinction between cabergoline and SAMe in regards to stimulation of the dopaminergic system (and subsequently prolactin inhibition and/or antidepressant actions) is really summed up with this basic thought:
SAMe: improves dopamine receptor site binding; quick onset and short-acting
Cabergoline (Dostinex): dopamine agonist; quick onset BUT long-acting
So, an effective answer to your question is NO - it isn't exactly the same nor will it likely provide the same level of prolactin inhibition. What I could see happening is starting someone with prolactin-induced gyno etc... with Cabergoline and transferring them into SAMe dosing. SAMe "may" aid cabergoline binding overall, but this is really unclear at this point. This will likely show up in future research for sure.
D_
|
thanks dana,
did you get the email i sent you from jowen88@gmail.com about prolactin and trenadrol?
|
|
|
|
01-23-2008, 01:25 PM
|
#4
|
|
Status: IFFI
Join Date: Jun 2007
Location: San Diego
Age: 27
Posts: 757
|
Quote:
Originally Posted by dinoiii
So, an effective answer to your question is NO - it isn't exactly the same nor will it likely provide the same level of prolactin inhibition. What I could see happening is starting someone with prolactin-induced gyno etc... with Cabergoline and transferring them into SAMe dosing. SAMe "may" aid cabergoline binding overall, but this is really unclear at this point. This will likely show up in future research for sure.
D_
|
Why do I have a feeling that I am the future research as Im the one noted for this case most often.... I dont like where this is going lol 
__________________
IFFI Resident Guinea Pig
If you're planning on running a cycle based on one of mine, or my advice: please note that I am not a doctor nor an expert. Posts are suggestions/opinions only - and marginally insane at that. Consult your doctor before use of any supplement.
Forum perusal is a gynecomastia agonist.
|
|
|
|
01-23-2008, 02:44 PM
|
#5
|
|
Status: IFFI Control Tower
Join Date: Jun 2007
Location: Columbus, OH / Rochester, NY / Baltimore, Md / Others
Posts: 2,772
|
Quote:
Originally Posted by Owen70
thanks dana,
did you get the email i sent you from jowen88@gmail.com about prolactin and trenadrol?
|
Have to check on that. Since my sister's incident I have been a bit more backed up in the email dept., but this should start to even itself out now that she is becoming more responsive.
Quote:
Originally Posted by Voodoo
Why do I have a feeling that I am the future research as Im the one noted for this case most often.... I dont like where this is going lol 
|
Well, your signature implies you are opt for "guinea pig" status, no?
D_
__________________
Dana Houser, MD, MHSA, CISSN
Professional Associations: AACE, TES, ADA, ACP, ATA, PS, TOS, NLA, ASBMR, SHM, IHS, HPTHA, NSCA, ISSN
askdinoiii@hotmail.com
The Clinical Underground Official Newsletter (Volume I, Issues I & II now available) ... send "subscribe" email to the address above.
Disclaimer: Despite my being a physician, the information provided in my posts is intended for INFORMATIONAL PURPOSES ONLY and to stimulate increased rapport between physician and patient. It is asked that you embark on advice provided solely by your EXAMINING physician.
Please do NOT email, PM for scripts or referral.
|
|
|
|
01-23-2008, 04:10 PM
|
#6
|
|
Status: IFFI
Join Date: Jun 2007
Location: San Diego
Age: 27
Posts: 757
|
Quote:
Originally Posted by dinoiii
Well, your signature implies you are opt for "guinea pig" status, no?
D_
|
so long as our collective learning curve is reversable.
__________________
IFFI Resident Guinea Pig
If you're planning on running a cycle based on one of mine, or my advice: please note that I am not a doctor nor an expert. Posts are suggestions/opinions only - and marginally insane at that. Consult your doctor before use of any supplement.
Forum perusal is a gynecomastia agonist.
|
|
|
|
01-24-2008, 11:08 AM
|
#7
|
|
Status: IFFI Control Tower
Join Date: Jun 2007
Location: Columbus, OH / Rochester, NY / Baltimore, Md / Others
Posts: 2,772
|
Quote:
Originally Posted by Voodoo
so long as our collective learning curve is reversable.
|
point taken.
[holds off on year supply shipment of SAMe to Voo...]
D_
__________________
Dana Houser, MD, MHSA, CISSN
Professional Associations: AACE, TES, ADA, ACP, ATA, PS, TOS, NLA, ASBMR, SHM, IHS, HPTHA, NSCA, ISSN
askdinoiii@hotmail.com
The Clinical Underground Official Newsletter (Volume I, Issues I & II now available) ... send "subscribe" email to the address above.
Disclaimer: Despite my being a physician, the information provided in my posts is intended for INFORMATIONAL PURPOSES ONLY and to stimulate increased rapport between physician and patient. It is asked that you embark on advice provided solely by your EXAMINING physician.
Please do NOT email, PM for scripts or referral.
|
|
|
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is Off
|
|
|
All times are GMT -5. The time now is 10:14 PM.
|
|